QUOTED. April 19, 2019. Matt Likens.
GT Medical Technologies Inc. launched GammaTile permanent intracranial brachytherapy device, designed to be placed in the space left after the excision of a brain tumor. See what GT Medical Technologies' CEO and president Matt Likens said about it here.
"Basically, [with GammaTile], you're tiling the wall of the cavity that's created by resecting the tumor – very simple, very straightforward. It doesn't disrupt the workflow in the operating suite at all. And the structural offset is so critical to the safety profile." –Matt Likens, president and CEO, GT Medical Technologies
- Find out more: Start-Up Spotlight: GT Medical Technologies' GammaTile Brings Brachytherapy Directly To Brain Tumors
Click here for a free trial of Medtech Insight